Bank Julius Baer & Co. Ltd, Zurich Mannkind Corp Transaction History

Bank Julius Baer & Co. Ltd, Zurich

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 09, 2022	SELL	$2.62 - $4.45 $31,440 - $53,400	-12,000 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$3.89 - $5.48 $283 - $400	73 Added 0.61%	12,000 $52,000
Q2 2021 Jul 23, 2021	SELL	$3.61 - $5.45 $263 - $397	-73 Reduced 0.61%	11,927 $65,000
Q1 2021 May 10, 2021	SELL	$3.14 - $6.14 $442 - $865	-141 Reduced 1.16%	12,000 $47,000
Q4 2020 Feb 24, 2021	BUY	$1.79 - $4.04 $252 - $569	141 Added 1.18%	12,141 $38,000
Q2 2020 Aug 12, 2020	BUY	$0.94 - $2.21 $292 - $687	311 Added 2.66%	12,000 $21,000
Q1 2020 May 13, 2020	BUY	$0.84 - $1.76 $9,818 - $20,572	11,689 New	11,689 $12,000

245

148M

1.62M

802K

Ticker MNKD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 257,338,000
Market Cap $1.75B
Description
MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...

Get notified when there are updates to the investment portfolio of Bank Julius Baer & Co. Ltd, Zurich, based on Form 13F filings with the SEC.

Stay updated on Bank Julius Baer & Co. Ltd, Zurich with notifications on news.